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Use of Perfusion Bioreactors and Large Animal
Models for Long Bone Tissue Engineering
Leandro S. Gardel, PhD,1–4 Luı´s A. Serra, PhD,5 Rui L. Reis, PhD,1–3 and Manuela E. Gomes, PhD1–3
Tissue engineering and regenerative medicine (TERM) strategies for generation of new bone tissue includes the
combined use of autologous or heterologous mesenchymal stem cells (MSC) and three-dimensional (3D) scaffold
materials serving as structural support for the cells, that develop into tissue-like substitutes under appropriate
in vitro culture conditions. This approach is very important due to the limitations and risks associated with
autologous, as well as allogenic bone grafiting procedures currently used. However, the cultivation of osteo-
progenitor cells in 3D scaffolds presents several challenges, such as the efficient transport of nutrient and oxygen
and removal of waste products from the cells in the interior of the scaffold. In this context, perfusion bioreactor
systems are key components for bone TERM, as many recent studies have shown that such systems can provide
dynamic environments with enhanced diffusion of nutrients and therefore, perfusion can be used to generate
grafts of clinically relevant sizes and shapes. Nevertheless, to determine whether a developed tissue-like sub-
stitute conforms to the requirements of biocompatibility, mechanical stability and safety, it must undergo
rigorous testing both in vitro and in vivo. Results from in vitro studies can be difficult to extrapolate to the in vivo
situation, and for this reason, the use of animal models is often an essential step in the testing of orthopedic
implants before clinical use in humans. This review provides an overview of the concepts, advantages, and
challenges associated with different types of perfusion bioreactor systems, particularly focusing on systems that
may enable the generation of critical size tissue engineered constructs. Furthermore, this review discusses some
of the most frequently used animal models, such as sheep and goats, to study the in vivo functionality of bone
implant materials, in critical size defects.
Introduction
The tissue engineering and regenerative medicine(TERM) field has expanded rapidly as new discoveries
are made that render possible tissue replacement and re-
generation. Considering the body’s tissues biochemical,
biophysical and hydrodynamic requirements, functional tis-
sue engineering requires the development of new tools for
in vitro tissue culture, to create a biotissue that can develop
in vivo, and replace damaged tissue.1,2 Moreover, the in-
creasing patient demand for tissue-engineered products and
therapies requires technologies for large scale production of
tissue substitutes with precise control of shape/size and high
quality.3–6 Bioreactors can be defined as devices in which
biological or biochemical processes, or both, are re-enacted
under controlled conditions (for example, pH, temperature,
pressure, oxygen supply, nutrient supply, and waste re-
moval). Originally most bioreactors were developed to test
biomaterials but some of them were also invented with the
objective of enabling extracorporal tissue growth.7 In fact,
bioreactors might facilitate the aseptic growth of functional
tissues and simultaneously offer several further advantages
over culture in plates and flasks.8,9 In addition, bioreactors
can be custom designed for engineering tissues with complex
three-dimensional (3D) geometry containing multiple cell
types.10 The fact that physical stimuli can modulate cell
function and tissue development has further motivated the
development of biomechanically active stimulation systems
to culture functional cell-tissues constructs in vitro by ex-
posing them to physiologically relevant mechanical and/or
hydrodynamic stimulation. The overall goal is to have sys-
tems that reliably and reproducibly form, store, and deliver
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functional tissues substitutes that can sustain function
in vivo. In essence, the bioreactor needs to provide the ap-
propriate physical stimulation to cells, continuous supply of
nutrients (e.g., glucose, amino acids), biochemical factors,
and oxygen, diffusion of chemical species to the construct
interior, as well as continuous removal of by-products of
cellular metabolism (e.g., lactic acid).11 In the absence of a
vascular blood supply in vitro, nutrient delivery to cells
throughout 3D tissue-engineered constructs grown in static
culture must occur by diffusion. As a result, thin tissues and
tissues that are naturally avascular (e.g., cartilage) have been
more readily grown in vitro than thicker, vascular tissues,
such as bone.12–14 The ex vivo generation of larger 3D tissue
substitutes particularly requires the development of enlarged
devices and systems that allow cells to distribute within a
wide 3D space, and at the same time satisfy the physico-
chemical demands of culturing such large cell masses into a
scaffold.6,15 Several international research groups have
demonstrated the advantages of using culture systems that
combine both hydrodynamic and mechanical stimulation
during tissue development.16–21 The vast majority of these
studies report on the development and use of perfusion
bioreactors, which are mostly composed of a perfusion pump
with one or more output channels where the flow can be
controlled and connected to single or multiple cell culture
chambers through silicone tubes, which allow the exchange
of gases (O2, CO2) between the culture medium and the
environment. Most of these groups work for the develop-
ment of new combinations of stem cells and materials con-
structs to obtain functional tissue-engineered constructs for
bone regeneration. Thus, they are also interested in devel-
oping and evaluating their concepts in highly reproducible
large segmental defects in preclinical large animal models.
These studies should allow the development of methods to
produce reliable data (biocompatibility, mechanical stability,
and safety), creating a real set of information to allow, in the
near future, the use of tissue engineered constructs of large
dimensions, specifically translating into the orthopedics
surgical field. This is an essential step in the process of as-
sessing newly developed bone grafts before clinical use in
humans. Animal models allow the evaluation of materials in
loaded or unloaded situations over potentially long time
durations and in different tissue qualities and ages. While
some animal models may closely represent the mechanical
and physiological human clinical situation, it must be re-
membered that it is only an approximation, with each animal
model having unique advantages and disadvantages.22 This
review examines the existent literature concerning the use of
perfusion bioreactors systems and large animal models to
evaluate tissue engineered constructs of large dimensions.
Bioreactors for Bone Tissue Engineering
For tissue engineering purposes, dynamic culture biore-
actors, such as spinner flasks,23,24 rotating wall bioreac-
tors,23,25 and flow perfusion systems,19,26 have shown
promising results. In general, dynamic culture yields a much
more homogeneous distribution of cells and matrix, while
systems enabling shear stresses applied by the medium flow
may stimulate the cells to proliferate and differentiate. Fur-
thermore, these systems enhance mass transport, ensuring
continuous nutrition of cells, and removal of waste products.
The commonly used spinner flasks are low cost equipment,
but the nonuniform media flow that is provided around
scaffolds limits their use. The cells on the outer periphery of
scaffolds are subjected to a turbulent flow, whereas the cells
in the interior rely on diffusion for nutrient transport.27 Si-
milar drawbacks are seen in the rotating wall bioreactor. In
these bioreactors, the use of scaffolds with different archi-
tectures leads to the generation of internal shear stresses of
different magnitudes, eventually leading to the localized
generation of extremely high shear forces, with negative ef-
fects in the cells. Some flow perfusion systems overcome the
flow issues because medium is flushed directly through
scaffolds,19,26 thereby providing nutrient and stimuli
throughout the entire volume of the scaffold.27 The design
and performance of bioreactors is therefore, of special rele-
vance in recent and future tissue engineering strategies.
Bioreactors that use a pump system to perfuse media directly
through a scaffold are known as perfusion bioreactors.28
Perfusion bioreactors with defined mechanical stimulation
functions are of special interest to optimize the ex vivo
growth of the desired cell or scaffold constructs.7,29 How-
ever, direct perfusion introduces a new level of complexity
when scale-up is considered, and the engineering challenges
may be significant.11
Nutrition, chemotransport enhancement, and mechanical
stimulation (dynamic tension, compression, or hydrody-
namic forces) of cells or cell/scaffold constructs, control over
environmental conditions, culture duration, on-line evalua-
tion of biological variables, and automation of bioprocesses
should be considered for the development and use of bio-
reactors.1,29–35 Moreover, bioreactors should to be able to
operate over long periods of time under aseptic conditions
since maturation of a functional tissue substitute may take
up to several weeks. Another important issue in the design of
bioreactors is the monitoring of tissue growth. In fact, an
advantage in the area would be the development and em-
ployment of techniques, which could assess the integrity of
the tissue noninvasively.11 Oxygen and nutrient need and its
consumption by the cells, metabolite removal and fluid flow
within the site have a dramatic impact on the growth and
survival of enlarged constructs for tissue substitution, and
when controlled can be used as major positive modulators in
elaborated bioreactors. This would allow for a higher effi-
ciency in the tissue engineering process, as well as a high
degree of certainty in obtaining grafts within the pre-
determined manufacturing specifications.
Perfusion bioreactors
In addition to enhancing mass transport, perfusion bio-
reactors systems may be used to deliver controlled me-
chanical stimuli, such as flow-mediated shear stresses and/
or hydrodynamic forces to tissue constructs.36–38 Different
perfusion bioreactor have been developed but most systems
consist of a similar basic design consisting of a media res-
ervoir, a pump, a tubing circuit, and perfusion chambers,
columns or cartridges that hold the cell/scaffold constructs.39
Perfusion bioreactor systems have been developed to culture
a variety of shapes and sizes of 3D bone tissue con-
structs.19,25,40–54 In these systems, it is obvious that the flow-
rate used for the medium perfusion is responsible to a great
extent for the effects in the microenvironment of cells, that is,
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for the magnitude of the shear stress sensed by the cells.
Porter et al. (2005) estimated the local shear stresses inside 3D
natural scaffolds using the lattice Boltzmann method (LBM)
for cell culture media flow through trabecular bone, per-
forming reconstructions using microcomputed tomography
(mCT).55 Based on this study, mCT has been used in con-
junction with fluid dynamics simulations, to characterize the
distribution of shear stresses within 3D scaffolds.56,57
Nevertheless, the local internal shear stress created by per-
fusion systems using hydrodynamic forces and experienced
by the cells on 3D matrices, is influenced not only by the
medium flow rate but also by other parameters that have to
be considered, for example, the porosity, the dimensions, the
material and the geometry of the scaffold,58 as well as the
existence of manufacturing defects that create areas of high
flow and high stress along the periphery of the scaffold56 the
size, the anisotropy, and the degree of interconnectivity of
pores, as well as the viscosity of the medium.58
Nowadays, multidisciplinary efforts are being made to
improve the size and quality of the bone substitutes that can
be obtained in vitro. These efforts focus on the cell types
used, scaffold structure/composition, and also on the culti-
vation in perfusion bioreactor systems with various designs.
However, most studies on perfusion bioreactors describe
systems that only enable culturing small scaffolds, which do
not meet clinically relevant constructs size in the field of
orthopedics defects regeneration. In the following sections,
the main differences between two basic types of perfusion
bioreactors (with individual culture chambers and single
culture chamber), which enable to culture scaffolds with
different dimensions, are described and discussed in the
light of the current clinical need for larger engineered bone
substitutes.
Perfusion bioreactors with individual culture chambers for
culturing small dimension constructs. In flow perfusion
systems composed of individual chambers, usually the
scaffolds are fitted in the culture chambers so that media
cannot flow around it; thus, perfusing media directly
through the pores of the scaffold. The flow of medium
through the scaffold porosity benefits cell differentiation by
enhancing nutrient transport to the scaffold interior, and by
providing mechanical stimulation in the form of shear
stresses.49,55,59 In fact, studies with perfusion systems have
suggested that flow has many biological effects,27,60–63 such
as prostaglandin E2 release,64 osteogenic differentiation en-
hancement,49 and mineralized matrix production increase on
bone marrow stromal osteoblasts seeded in 3D scaffolds.65
Research works using either custom-made or commercially
available perfusion bioreactor systems are specified in the
Table 1.
In 2001, Goldstein et al.25 compared a perfusion flow
bioreactor to other systems that promote media convection,
namely a spinner flask and a rotary vessel. For this purpose,
they used poly (DL-lactic-co-glycolic acid) (PLGA) foam discs
seeded with marrow stromal cells and cultured in the pres-
ence of dexamethasone and L-ascorbic acid, at a constant
flow rate. Cell numbers per foam were found to be similar
with all culturing systems indicating that cell growth could
not be enhanced by convection, but histological analysis in-
dicated that the rotary vessel and the flow system produced
a more uniform distribution of cells throughout the foams.
Alkaline phosphatase (ALP) activity per cell was higher with
culture in the flow system and spinner flask after 7 days,
while no difference in osteocalcin (OC) activity per cell was
observed among culturing methods after 14 days. Based on
these results, the flow system appears to be the superior
culturing method.25
In 2002, Bancroft et al.65 reported the development of an-
other flow perfusion bioreactor and investigated the effect of
different flow rates, in rat bone marrow cells seeded into
titanium fiber mesh scaffolds cultured in osteogenic media.
Culturing seeded scaffolds at different flow rates for 16 days
revealed a dose-dependent effect of flow perfusion rate on
mineralized matrix production, matrix modeling, and cell
matrix distribution. The latter was significantly higher in the
flow perfusion cultures when compared with static culture.65
van den Dolder et al., in 2003,63 used the same bioreactor,
biomaterial, culture medium and cells, to analyze the effect
of flow perfusion (as compared to static conditions), at a
constant flow rate, founding that this system can enhance the
early proliferation, differentiation, and mineralized matrix
production of rat bone marrow stromal cells.63
The same bioreactor developed by Bancroft et al., in
2002,65 was used in other studies, using different types of
scaffolds, such as porous biphasic calcium phosphate ce-
ramic scaffolds,49 poly(L-lactic acid) nonwoven fiber mesh
scaffolds,43 and starch polycaprolactone (SPCL) biodegrad-
able fiber mesh scaffolds.40,41 Furthermore, Holtorf et al., in
2005,66 showed that using this system, even in the absence of
dexamethasone supplement, rat BMSCs can differentiate into
osteoblastic.66 Gomes et al., in 200340 have also showed that
rat BMScs proliferation and differentiation are affected by the
scaffold’s porosity and architecture40 and reported increased
production and localization of TGF-b1, VEGF, BMP-2, and
FGF-2 in constructs cultured under increase fluid flow rate.41
Based on the same bioreactor design, Alvarez-Barreto et al.,
in 2007,67 developed and characterized an oscillatory flow-
perfusion seeding technique, to improve seeding efficiency,
cell spatial distribution and strength of cell adhesion. The
technique consisted in the application of an oscillating flow
for 2 h at 0.1mL/min that is created by manually changing
the direction of the pump every 5min.67 This technique led
to enhanced seeding efficiency and osteoblastic differentia-
tion of rat BMSC cultured in poly (glycolic acid) (PGA)
scaffolds.68 Bjerre and coworkers in 2008,69 performed an-
other modification of the same bioreactor. The modified
system consists of 16 parallel flow chambers, each supplied
by a common reservoir controlled by a peristaltic pump.
They analyzed the proliferation and differentiation of hMSC
cultured on silicate-substituted tricalcium phosphate (TCP)
scaffolds at a constant flow rate as compared to static culture.
Data obtained from ALP activity and RT-PCR analysis of
bone markers after 14 days in flow culture demonstrated an
increase in proliferation, differentiation and cell/matrix de-
position.69
The perfusion bioreactor from Minucells and Minutissue,
are one of the few commercially available culture systems
and has a different design: there is not a recirculation of the
culture medium as in most systems described; the culture
medium is perfused through 12 culture chambers in one
direction, each in a thermo plat (37C) in room temperature,
connected to another bottle (waste culture medium) where
the flow ends. This system was used by Wang et al., in
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2003,61 to culture bone marrow-derived cell in porous ce-
ramic scaffolds, using a constant flow rate. ALP and OC
expression were increased in perfusion cultures when com-
pared of static cultures.61
Wendt et al., in 200326 developed a bioreactor for auto-
mated cell seeding of 3D scaffolds by continuous perfusion
of a cell suspension through the scaffold pores in oscillating
directions. In this system, scaffolds are placed in chambers
(one scaffold per chamber) that are positioned at the bottoms
of two glass columns and connected through a U-shaped
glass tube at their base. Flow is induced with the use of a
vacuum pump and the flow rate regulated with a flow me-
ter. The direction of flow is reversed when the fluid level in
one column reaches an optical sensor placed near the top of
each glass column. The sensor detects the cell suspension,
actuating a pair of solenoid valves, switching the vacuum to
the opposite column, and therefore, reversing the direction of
fluid flow. To assess the efficiency and uniformity of perfu-
sion seeding of Polyactive foams ChronOS seeded with
bone marrow stromal cells (BMSCs), as compared to static
and spinner flask cultures, they used quantitative biochem-
ical and image analysis techniques. The results showed that
perfusion seeding of cells into Polyactive foams were more
homogeneously distributed throughout the scaffold volume
and formed more homogeneously sized cell clusters when
compared to other systems.26 Braccini et al., in 2005,70 used
the same system, to study the effect on seeding, expansion,
and differentiation of BMSCs into a 3D hydroxyapatite
scaffolds and subsequent in vivo outcomes. When implanted
ectopically in nude mice, the engineered constructs gener-
ated bone tissue more reproducibly, uniformly, and exten-
sively than scaffolds loaded with 2D expanded BMSCs.70
Zhao and Ma, in 2005,53 modified a 3D perfusion biore-
actor system developed previously by Ma et al., in 1999,71
which is composed of three circulating loops. The main cir-
culating loop includes culture chambers and a section of the
flow path for continuous circulation of medium. The inocu-
lation loop includes culture chambers and a section of the
flow path used for inoculating cells into scaffolds. The re-
plenishing loop consists of the fresh media container and the
section of the flow path used for supplying fresh media to
the system. The two inlets and two outlets in each chamber
are connected to independent inlets from the computerized
peristaltic pump that has eight independent channels. This
system enables the recirculation of media and has two
sampling ports at the inlet and outlet of each chamber.
Furthermore, it can accommodate multiple flow chambers,
depending on the operational requirements. To examine the
dynamic seeding efficiency, the author used nonwoven poly
(ethylene terepthalate) (PET) fibrous scaffolds cultured with
human mesenchymal stem cells (hMSC). They observed an
inverse correlation between flow rates for seeding operation
and seeding efficiencies and analyses showed that after a
long period of culture, higher cell densities of hMSCs were
found in the bioreactor system.53 With the same method and
biomaterial Zhao et al., in 2005,72 studied the effects of the
physiological oxygen environment on the intrinsic tissue
development characteristics in the 3D scaffolds as compared
to static conditions, using mathematical modeling. Results
show that the oxygen tension in the static culture is lower
compared with the perfusion unit, where the cell density was
four times higher.72 To demonstrate the effect of shear stress,
Zhao et al., in 2007,42 cultured porous 3D PET matrices with
hMSC at different flow rates in the same bioreactor. The
higher flow rate enhanced osteogenic differentiation poten-
tial at 14 days, and calcium deposition in the matrix after 20
days with osteogenic media.42
A perfusion bioreactor was developed by Timmins and
coworkers in 2007,73 the tissue culture under perfusion (T-
CUP), based on the concept of controlled and confined al-
ternating motion of scaffolds through a cell suspension or
culture medium, as opposed to pumping the fluid through
the scaffolds. Different cell types, as well as scaffold designs
and compositions were tested. When freshly isolated human
bone marrow nucleated cells seeded into ENGipore ceramic
scaffolds cultured for 19 days in the T-CUP resulted in
stromal cell-populated constructs capable of inducing ectopic
bone formation in nude mice.73
Grayson et al., in 2008,44 described a bioreactor system that
enables cultivation of up to six tissue constructs simulta-
neously in individual chambers, using a radial channel with
direct perfusion and imaging capability. Fully decellularized
bovine trabecular bone was used as a scaffold, seeded with
hMSCs using different cellular densities and different flow
rates (low and high). The results of the study indicated that,
at the seeding densities evaluated, greater initial cell num-
bers do not necessarily result in increased bone formation.
The study also showed that flow rate of medium perfusion
remains a significant parameter that allows a more uniform
tissue development and supports higher cell densities within
the constructs.44 Frohlich et al., in 2010,48 using the same
bioreactor showed that, human adipose-derived stem cells
(hASCs), cultured in decellularized bone scaffolds, after 5
weeks of culture in osteogenic medium, presented signifi-
cantly increases in the construct cellularity, and in the
amounts of bone matrix components.48
Costa et al., in 2008,74 developed a perfusion bioreactor
composed of 20 culture chambers, each one supporting a
single, tightly fitting scaffold. A peristaltic pump controls the
medium flow rate through the bioreactor, with silicon tubes
directly connected to the system and to a medium reservoir
(with recirculation flow). Using this system, a study was
conducted using SPCL meshes statically seeded with goat
bone marrow cells (gBMCs) and cultured in osteogenic me-
dium for 7 and 14 days. The results showed enhanced cel-
lular proliferation and differentiation by combination of fluid
flow rate and flow inversion frequency during different
culturing periods.74 Rodrigues et al. in 201275 has further
demonstrated the potential of this bioreactor, demonstrating
the positive influence of the flow perfusion conditions pro-
vided in the osteogenic differentiation of hASC seeded onto
SPCL fiber meshes functionalized with Silanol (SI-OH).
An oscillatory perfusion bioreactor was fabricated by Du
et al., in 2008.76 The upper chamber consisted of six flow
wells custom-machined in a block of Teflon. The base of each
well was sealed with a silicon film. The scaffold is press-
fitted to a silicon cassette that was then fixed into each well
with an upper O-ring and steel cap with up-to-down pres-
sure to ensure that the media would perfuse only through
the scaffold and not flow in between the scaffold and cassette
or between the cassette and well wall. The lower chamber is
filled with sterilized water using a 30-mL syringe with gas
removed from the gas outlet. The movement of the syringe
back and forth is controlled by a continuous cycle syringe
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pump, forcing the silicon membranes to move up and down;
thus, driving the media in the flow wells to perfuse up and
down through the scaffolds in an oscillatory manner. Results
obtained with a mouse immature osteoblast-like cell line, MC
3T3- E1 seeded in porous beta-TCP (b-TCP) scaffolds sug-
gested that the oscillatory flow condition not only allows a
better seeding efficiency and homogeneity, but also facili-
tates uniform culture and early osteogenic differentiation.76
The same group designed a unidirectional perfusion system.
A media bottle is set on each end of the perfusion chamber as
both media reservoirs and gas bubble trappers. A gas-per-
meable bag is set in the circuit loop as a gas exchanger. The
unidirectional media flow was driven by a pump. A couple
of silicon tubes led from bottle 2 to the clean bench, so that the
medium could be exchanged in a sterile environment without
moving the whole complicated system. This system presents a
recirculation flow; thus, media are drawn from the media
reservoir, pumped through the compartments, merged at the
outlets of the chambers, and returned back to the media res-
ervoir. The perfusion system with the scaffolds set inside is
sterilized by ethylene oxide gas. To compare these two dif-
ferent types of perfusion systems developed; mouse osteo-
blast-like MC 3T3-E1 cells were 3D-cultured with porous
ceramic scaffolds for 6 days under static and hydrodynamic
conditions with either a unidirectional or oscillatory flow. In
perfusion culture with the unidirectional flow, the prolifera-
tion was significantly higher than in the other groups but was
very inhomogeneous. Only the oscillatory flow allowed os-
teogenic cells to proliferate uniformly throughout the scaf-
folds, and also increased the activity of ALP.35
Sailon et al., in 2009,54 developed a flow perfusion cham-
ber bioreactor with eight individual chambers to provide
chemotransportation in thick scaffolds. Polyurethane scaf-
folds, seeded with murine preosteoblasts, were cultured.
Flow-perfused scaffolds demonstrated increase in peripheral
cell density and core density at day 8. This study established
that thick (> 6mm) 3D constructs are sustainable using a
flow-perfusion bioreactor.54
Yang and coworkers, in 2010,47 developed a perfusion
system that is composed of six culture cassettes, a multi-
channel cylinder pump, and a medium reservoir. Each cul-
ture cassette contained a screw-top, a neoprene o-ring, and a
screw-bottom with an internal cavity. The scaffold is press-
fitted on a net in the internal cavity of the screw-bottom.
Media flows from top to bottom through the scaffold. Flow
through each cassette is driven by the cylinder pump with
each culture cassette on its own independent pumping cir-
cuit. In the complete perfusion culture circuit, media are
drawn from the common media reservoir, pumped through
each culture cassette, and returned to the common media
reservoir. The entire flow circuit is connected with silicon
tubing. Using hMSCs transduced with human telomerase
catalytic subunit hTERT (hTERT-hMSCs) cultured in porous
PLGA scaffolds under perfusion for 12 days at a flow rate of
0.5mL/min, they demonstrated that the flow enhances os-
teogenic proliferation and differentiation of hTERT–hMSCs,
when compared to static conditions.47
More recently, Kim et al. in 2011, built an electrical bio-
reactor, composed of a cylindrical Teflon main part con-
taining a flexible polyimide electrode and an implantable
stimulator. The main part has about 300 holes with a diam-
eter of 300mm for medium supply inside the bioreactor and
has a length of 17mm and a diameter of 8mm. Upon seeding
hMSCs onto collagen sponges (aimed at forming a bone
tissue graft), they have cultured the constructs in the biore-
actor under biphasic electric current (BEC) stimulation. BEC
stimulation with amplitude of 20/40mA, duration of 100ms
and a frequency of 100Hz was applied for 1 week in the
early periods of culturing. Subsequently, after culturing for
an additional week without electrical stimulation, cell re-
sponse was evaluated in terms of proliferation, attachment
and gene expression. In vitro culture of hMSCs under stim-
ulation showed 19% and 22% increase in cell proliferation, as
compared to unstimulated controls. The expression of type I
collagen also increased significantly in the cells submitted to
the BEC. The results showed that this electrical bioreactor
may enhance the efficiency of stem cell-based tissue engi-
neering77 approaches.
To visualize and to examine the effect of shear stress in the
a tubular perfusion system (TPS) bioreactor, Yeatts et al. in
2012,78 used hMSCs seeded and cultured into spherical al-
ginate bead scaffolds of two sizes. After 21 days of culture, it
was observed a strong correlation of the shear stress in
hMSC osteoblastic differentiation indicated by the produc-
tion of osteopontin, and bone morphogenic protein-2. Fur-
ther results revealed an approximate 2.5-fold increase in cell
number in the inner annulus of TPS cultured constructs as
compared to statically cultured constructs after 21 days. It
was also observed a significant increase in mineralization in
the inner and outer regions of the beads (4mm) scaffolds
cultured in the bioreactor on day 21, when compared to
those cultured in static conditions. These results demonstrate
a relationship between scaffold position and stem cell fate in
this bioreactor and further demonstrate also the importance
of bioreactor systems in promoting hMSC proliferation and
differentiation in 3D scaffolds.78
Knapp and coauthors in 2012,79 built a custom-made
bioreactor for bone tissue engineering, where they have
cultured a macroporous hydrogels disc-shaped with adipose-
derived stem cells (ASC), using noninductive ostegenic me-
dia (IMDM + 10% FCS), under pulsatile flow rate conditions.
Results demonstrated that dynamic cultures provided a
strong osteogenic induction with 100-fold higher levels of
ALP and OC mRNA.79
Fan et al., in 2012,80 cultured tri-calcium phosphate scaffolds
(12mm in diameter and 10mm in height) of different poros-
ities (Low, Medium and High) in static and perfusion condi-
tions using a custom-made perfusion bioreactor. Results
demonstrated that higher permeable scaffolds exhibited su-
perior performance and that the advantages of higher scaffold
permeability were amplified in the perfusion culture.80
Qian et al. in 2013,81 studied a porous nanohydrox-
yapatite/polyamide 66 (n-HA/PA66) scaffold with a size of
16mm in diameter and 1.5mm in thickness, drilling one hole
of 2.5mm and three holes of 1.5mm diameter in the material.
The scaffolds seeded with rat bone marrow stromal cells
(rBMSCs) were cultured under the static conditions and in a
flow perfusion bioreactor. The results showed that values of
MTT, ALP, and osteocalcin (OCN) were continuously in-
creased along time in culture and revealed significant higher
levels for the group cultured under perfusion conditions.81
Nishi et al. in 2013,82 performed a study addressing the
issue of vascularization in bone tissue engineering, by co-
culturing bone marrowMSCs with MSC-derived endothelial
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cells within a porous scaffold composed of D,D-L,L-poly-
lactic acid (cylinder of 5mm in diameter and 2mm thickness)
using a rotating wall vessel (RWV) bioreactor. Overall, the
results obtained by histochemical analyzes showed that it
was possible to generate a bone-like tissue containing vas-
cular-like structures using a 3D matrix cultures under con-
ditions created by the medium flow in the RWV vessel.82
Single culture chamber perfusion bioreactors that enable
culturing large sized constructs. As seen in the previous
section, many research groups have developed bioreactors
that perfuse cell seeded constructs, and that have demon-
strated the beneficial effects of perfusion on cell survival,
proliferation, differentiation, and extracellular matrix for-
mation in the scaffold. However, these studies focus on the
construction of small-size tissue-engineered bone ranging
from 0.04 to 2.7 cm3.25,27,40,44,48,54,55,59,63–65,69,76,83 In this
section, we will describe some of the available systems that
may enable the culture of large dimension constructs.
According to published works there has been an increas-
ing focus on the development of such bioreactors, which are
usually designed with a single cellular culture chamber.
Hosseinkhani et al., in 2005,50 developed a perfusion biore-
actor in which the cell-seeded scaffolds are set in a sample
holder, while the medium flowed by a peristaltic pump at a
linear flow velocity to perfuse the medium through the
scaffold, using a medium recirculation method and only one
medium reservoir. The perfusion system is operated in a CO2
incubator atmosphere. It was found that this system enabled
improvement of MSCs proliferation and differentiation in
collagen sponges reinforced with PGA fibers.50 Furthermore,
in another study, it was shown that BMP-2 expression of rat
MSCs impregnated with plasmid DNA encoding for BMP-2
was enhanced with perfusion culture.86 In a subsequent
in vivo study, the collagen–PGA scaffolds of 12mm diameter
seeded with rat MSCs were implanted ectopically in Fischer
male rats. Significant increase in ALP and OC expression at
sites of implantation of constructs previously cultured in the
perfusion system was observed as compared to constructs
obtained in static conditions.87
Xie et al., in 2006,88 described a bioreactor system that is
composed of three parts: the driving part, the reservoir, and
the tubing part. The driving part consists of up to eight 3-stop
tubes, which are fixed in an eight-channel pump head and
driven by a peristaltic pump. The reservoir (only chamber) is a
75-cm2 flask containing the perfusion medium. In the tubing
part, there are two silicone tubes with one end penetrating
through the plug cap into the flask as the inlet and outlet. To
study the effects of flow shear stress and mass transport, re-
spectively, on the construction of a large-scale tissue-engineered
bone substitute, Li et al.,45 used a critical-sized b-TCP cylinder
scaffold (14mm in diameter and 30mm in length with a
tunnel of the 3.5mm in diameter and 25mm in length) seeded
with hBMSCs. The results suggested that shear stress accel-
erates osteoblastic differentiation of hBMSCs, while mass
transport increases differentiation among lower ranges.45,88
A direct semiautomated perfusion bioreactor system
(single chamber) was developed by Janssen and his re-
searchers.89 Goat bone marrow stromal cells (GBMSCs) were
dynamically seeded/cultured in this system in volumes
(10 cm3) of small-sized macroporous biphasic calcium phos-
phate (BCP) scaffolds. Cell load and distribution was shown
using methylene blue block staining, and MTT staining was
used to demonstrate the viability of the cells. Online oxygen
measurements were correlated with proliferating GBMSCs.
They conclude that this bioreactor enabled homogenous cell
growth of GBMSCs.90 In posterior studies, the authors
demonstrated that dynamically cultured GBMSCs grown on
calcium phosphate ceramic produced bone when implanted
into mice.51 Another study conducted in 2010 by the same
group, concluded that this perfusion bioreactor system is
capable of producing clinically relevant and viable amounts
of human tissue-engineered bone that exhibit bone-forming
potential after implantation in nude mice.89
Jaasma et al., in 2008,91 developed a flow perfusion
chamber bioreactor consisting of a syringe pump, a scaffold
chamber, and a media reservoir, which are connected via
gas-permeable, silicone tubing and tubing connectors. The
scaffold is held in place within a silicone O-ring and between
two machined polycarbonate pieces. The scaffold is main-
tained under *10% compression using aluminum spacers
and an O-ring inner diameter is larger than the flow path
diameter through the polycarbonate pieces of the scaffold
chamber. The scaffold chamber is designed to accommodate
compliant scaffolds, but stiff scaffolds can also be used by
adjusting the spacer height. The syringe pump is program-
mable to allow for the application of steady, pulsatile, and
oscillatory flow profiles, and can accommodate up to six 50-
mL syringes, which allows for the simultaneous culture of six
cell-seeded constructs. The authors used Collagen-GAG (CG)
scaffold with 12.7mm in diameter and 3.5mm of thickness
MC 3T3-E1 cells and four scaffolds were cultured simulta-
neously, but each one in a different bioreactor. Flow analysis
revealed that steady, pulsatile, and oscillatory flow profiles
were transferred from the pump to the scaffold. Comparing
to static, bioreactor culture of osteoblast seeded CG scaffolds
led to a decrease in cell number but stimulated an increase in
the production of prostaglandin E2, an early-stage bone
formation marker.91
Another study examined the effect of short term flow
perfusion bioreactor culture, before long-term static culture,
in the same bioreactor developed by Jaasma et al., in 2008.91
Human fetal osteoblasts (hFOB 1.19) were seeded onto CG
scaffolds. Results show that the bioreactor and static culture
control groups displayed similar cell numbers and metabolic
activity. However, histologically, peripheral cell-encapsulation
was observed in the static controls, whereas, improved
migration and homogenous cell distribution was seen in the
bioreactor groups. Osteogenic markers investigated dis-
played greater levels of expression in the bioreactor groups
compared to static controls. They demonstrated that this
flow perfusion bioreactor improved construct homogeneity
by preventing peripheral encapsulation whilst also providing
an enhanced osteogenic phenotype over static controls.92
Barthold and other researches, in 2005,93 constructed a
perfusion chamber bioreactor (single chamber), to analyze and
identify soluble factors, such as the formation of l-lactate,
lactate dehydrogenase, collagen I C-terminal propeptide,
soluble ALP and OC during the culture of rabbit bone
marrow MSCs to get detailed information about the differ-
entiation of the osteogenic cells.93 This same bioreactor was
used to test human trabecular bone cells seeded onto three
different types of scaffolds (porous CaCO3, mineralized
collagen, porous TCP), with 5mm in diameter and 3mm
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thick, were used, stacking nine samples that were simulta-
neously cultured in the bioreactor. The scaffolds were sub-
sequently implanted in rat mandibules for 6 weeks. Scaffolds
without cells and scaffolds cultured in static conditions were
used as controls. Histomorphometric evaluation showed that
neither seeding human trabecular bone cells nor the cultur-
ing technique increased the amount of early bone formation
compared with the level provided by osteoconductive bone
ingrowth from the defect edges.94
To engineer anatomically correct pieces, Grayson and his
researcher’s46 report showed that clinically sized, anatomi-
cally shaped, viable human bone grafts can be developed
using hMSCs and a ‘‘biomimetic’’ scaffold-bioreactor system.
They selected the temporomandibular joint (TMJ) condylar
bone as their tissue model. Scaffolds were generated from
fully decellularized trabecular bone by using digitized clin-
ical images, seeded with hMSCs, and cultured with inter-
stitial flow of culture medium. A bioreactor with a single
chamber in the exact shape of a human TMJ was designed
for controllable perfusion throughout the engineered con-
struct. After 5 weeks of culture, tissue growth was evidenced
by the formation of confluent layers of lamellar bone, a
markedly increased volume of mineralized matrix, and the
formation of osteoids.46 Yeatts et al.,95 developed a bioreac-
tor- the TPS - consisting of a tubular growth chamber and
medium reservoir connected via a tubing circuit. The medi-
um’s flow is driven by a Multichannel peristaltic pump at
3mL/min for short-term studies and at either 3 or 10mL/
min for the long-term studies. The circuit consists of silicone
tubing that is connected using silver ion-lined microbial re-
sistant tubing connector. The growth chamber consists of
length silicone tubing. The growth chamber has 13 cm in
length and is packed with 30 cell seeded alginate beads. The
tubing is placed in a cell culture CO2 incubator atmosphere.
hMSCs were encapsulated in alginate beads (a total of 30
samples of 4mm diameter per bioreactor) and medium was
perfused through the growth chamber and around the
tightly packed scaffolds enhancing nutrient transfer, while
exposing the cells to shear stress. Results demonstrate that
bioreactor culture supports early osteoblastic differentiation
of hMSCs as shown by ALP gene expression and increases in
the gene expression levels of OC, OP, and bone morphoge-
netic protein (BMP)-2.95
Bertrand et al., in 2011,96 build a single chamber perfusion
bioreactor based on fluidized bed bioreactor concepts for
culture of clinical size scaffolds. It consists of a vertical cy-
lindrical polycarbonate chamber connected to a reservoir
containing the culture medium in a closed loop arrangement.
The connections between the bioreactor chamber and the
reservoir and between the bioreactor and a peristaltic roller
pump are made of silicone tubing, Multiple perfusion bio-
reactors, such as this were operated during experiments,
using 140 units of coral scaffolds (each 3· 3· 3mm3) for each
bioreactor, and seeded with GFP-C3H10T1/2 cells. To es-
tablish the flow influence, an in vitro study was conducted
with various flow rates. To investigate the osteogenic po-
tential of bone constructs, an in vivo study was carried out
using sheep MSCs, which were then subcutaneously im-
planted. The best flow rate determined for this bioreactor
and this scaffold was the 10mL/min and 8 weeks as fol-
lowing the subcutaneous implantation in sheep, all retrieved
samples had areas of mineralized bone and osteoid, with
osteocytes located inside the matrix and a film of osteoblasts
coating the newly deposited bone.96
Gardel et al., in 2013,97 developed a single chamber Bi-
directional Continuous Perfusion Bioreactor (BCPB). The
BCPB is composed by one vacuum and one peristaltic pump,
connected through of a circular flow system, which are
connected via gas-permeable, silicone tubing and tubing
connectors, and also for rotational engines located in specific
places, aiming at creating shears stresses, due to the medium
flow perfusion using different gradients of pressure, to in-
duce mechanical stimulations to the cells seeded onto the
scaffolds. The passage of the flow from the interior to the
exterior of the 3D support or from the exterior to the interior
of the 3D support is carried out through the use of a rigid
tube (polycarbonate) with perforations in its central part and
that has the same length of the 3D support (that can have
variable dimensions). This tube, containing the scaffold, is
connected to a circular system and is located coaxially inside
of the culture chamber. This culture chamber has four exits/
entrances and is tightly closed, by that same circular system,
which allows the control of the flow and the gradient of
pressure inside of the chamber and inside of the perforated
tube. Therefore, this system enables to control the perfusion
rate and gradient of flow, in the interior of the cell-scaffold
constructs in culture, and it allow to culture constructs of
significant dimensions, as it enable the access of nutrients to
the interior of the material and the removal of the metabolic
products from the interior of this, enabling the maintenance
of the cells the viability. To prove the feasibility of this per-
fusion system, preliminary in vitro studies using SPCL fib-
bers mesh scaffolds (with 16mm in diameter and 3mm
thickness with a concentric hole of 6mm), were seeded with
goat marrow stromal cells with and stacked, completing a
42mm thick construct. The samples were cultured for a pe-
riod of 14 and 21 days of culture in the bioreactor at a flow
rate of 1mL/min, using static cultured constructs as controls.
The results showed higher ALP activity levels in dynamic
cultures (14 days of culture) than those obtained under static
conditions. SEM and histological images showed cells occu-
pying the interior of the scaffolds cultured in the bioreactor,
while cells were predominantly on the surface of the GBMC–
SPCL constructs in the static cultures.97
In summary, the systems currently available for the cul-
ture of large sized constructs, described in this review, differ
considerably with respect to ease of use, cost-effectiveness,
and degree of additional osteogenic stimuli provided, as well
as monitoring and manipulation options. Further optimiza-
tion of these systems may be achieved by adapting specific
stimuli and by combining biophysical and biochemical
stimuli within one system. However, a major challenge will
be the translation of such bioreactor-based concepts into
clinically applicable designs, because this requires adapting
current designs or developing new bioreactors that enable
culturing constructs of large dimension for clinical use, in
accordance with Good Manufacturing Practices.
Large Animal Models
Selection of appropriate animal models
Desirable attributes of an animal model include demon-
stration of similarities with humans, both in terms of phys-
iological and pathological considerations, as well as being
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able to observe numerous subjects over a relatively short
time frame.98,99 When deciding on the species of animal for a
particular model there are several factors that should be
considered, namely cost to acquire and care for animals,
availability, acceptability to society, tolerance to captivity,
and ease of housing. The welfare and housing of animals is
usually covered by a Federal Animal Protection Act and may
vary slightly between countries. The Animal Protection acts
outline the minimum requirements in terms of housing di-
mensions, lighting, flooring etc. and must be complied with
when undertaking an animal study. Other factors include
low maintenance care, ease of handling, resistance to infec-
tion and disease, inter-animal uniformity, tolerance to sur-
gery, adequate facilities, support staff, and an existing
database of biological information for the species, ease of
adaptability to experimental manipulation, ecological con-
sequences and ethical implications.22,100 More specifically,
for studies investigating bone-implant interactions, an un-
derstanding of the species specific bone characteristics–such
as bone microstructure and composition, as well as bone
modeling and remodeling properties, are important when
later extrapolating the results to the human situation. Finally
the size of the animal must be considered to ensure that it is
appropriate for the number and size of implants chosen.22
Within a field of study, no single animal model will be
appropriate for all purposes, nor can a model be dismissed as
inappropriate for all purposes. Furthermore, multiple model
systems are likely required to establish a broad body of
knowledge.101 International standards established regarding
the species suitable for testing implantation of materials in
bone, state that dog, sheep, goat, pig are suitable large ani-
mal models. At least two of each of the species mentioned
above should be used for assessing each treatment at each
implantation period.22
Animal models in bone repair research
Animal models in bone repair research include represen-
tations of normal fracture healing, segmental bone defects,
and fracture nonunions in which regular healing processes
are compromised with the presence of a critical-sized defect
site.102 In critical-sized segmental defect, models bridging of
the respective defect does not occur despite a sufficient bio-
logical microenvironment, due to the removal of critical
amounts of bone substance. In contrast, in a true nonunion
deficient signaling mechanism, biomechanical stimuli or
cellular responses may prevent defect healing rather than the
defect size.103 Bone composition and biology of dog, sheep,
goat, and pig are very similar to those of humans. Reviews of
the literature comparing bone structure, composition, and
biology in these animals identify modest differences in can-
cellous and cortical bone density at various sites, magnitude
of sexual dimorphism, the age at which peak bone mass is
achieved, and the rate and extent to which haversian re-
modeling replaces plexiform lamellar bone in the cortex of
long bone.104 However, these points of variation do not
provide evidence that any one of these animals provides a
better match for human bone biology than the other.105 In a
variety of study designs, pigs are considered the animal of
choice and were described as a highly representative model
of human bone regeneration processes in respect to ana-
tomical and morphological features, healing capacity and
remodeling, bone mineral density and concentration.106,107
Pigs tend to be least used,108 likely due to difficult temper-
ament, anatomically short and thick long bones, and large
size. The short bones do not allow for large gap defects be-
cause adequate fixation is difficult to achieve,105 which leads
to the need for special implants, as one cannot use implants
designed for human use.103 Nonhuman Primates (NHPs) are
sometimes held up as the model of choice for prediction of
clinical performance for bone repair and regeneration
methods. This supposition is based on arguments of evolu-
tionary proximity and similar structural anatomic, endo-
crine, digestive, and dietary features and immunology. Of
the three common NHP species, only the baboon approaches
the skeletal size range that humans share with large canines,
sheep, and goats. NHPs are very expensive and present
husbandry challenges that preclude models involving in-
tensive wound assessment, management, or immobilization.
Although NHPs do not have companion animal status, ar-
guments of perceived evolutionary affiliation raise social and
ethic questions related to increasing their use in research.105
Dogs are used most due to a rich background of prior ex-
perience, ease of husbandry, and accessibility. A large liter-
ature characterizing canine models supports continued
preferential use of dogs in many settings, particularly in bone
marrow biology and transplantation immunology.109–115 The
use of dogs is being challenged, however, by social concerns
regarding the dog as a companion animal.105 Although, the
use of dogs as experimental models has significantly de-
creased mainly due to ethical issues, between 1998 and 2008
*9% of articles published in leading orthopedic and mus-
culoskeletal journals described dogs as animal models for
fracture healing research.108 Mature sheep and goats possess
a body weight comparable to adult humans and long bone
dimensions enabling the use of human implants.116 Sheep
are readily available and docile, but can be frail and less
resilient, particularly when not in a group. Goats are similar
in size and skeletal anatomy to sheep; they have a thinner
coat and less muscular bulk, and are more tolerant of stress
and isolation.105 The mechanical loading environment oc-
curring is well understood.117,118 Since no major differences
in mineral composition119 are evident and both metabolic
and bone remodeling rates are akin to humans,120 sheep and
goats are considered a valuable models for human bone
turnover and remodeling activity,103,121 making them an in-
creasingly viable alternative for bone research.105
Ovine models
Ovines are a convenient large animal model for biomedi-
cal research because of ease of handling and housing, animal
cost and acceptance to society as a research animal.122 Sheep
are long boned, and allow the use of many systems of in-
ternal fixation. Sheep are readily available and docile, but
can be frail and less resilient, particularly when not in a
group.105 They are a less expensive animal model versus
other species, and their size is conducive to the insertion of
prosthetic implants comparable to those implanted in hu-
mans. The age of the animals, the timing of the study, and
the duration of the experiment have to be considered in
sheep versus other species. The use of a few widely accepted
standardized sheep breeds would make interlaboratory
comparisons easier, and disclosure of reproductive and
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dietary histories could further aid our understanding of the
efficacy of this animal model.104 The number of sheep used
in orthopedic research is increasing in the last decade in-
volving fractures, osteoporosis, bone-lengthening and oste-
oarthritis, in comparison with companion animals.123 This
increase in usage may be related to the ethical issues and
negative public perception of using companion animals for
medical research.22 Adult sheep offer the advantage of hav-
ing a more similar body weight to humans and having long
bones of dimensions suitable for the implantation of human
implants and prostheses.116 Sheep are described as having a
predominantly primary bone structure in comparison with
the largely secondary bone of humans. Age-related changes
in bone structure are also described; adult sheep have a
plexiform bone structure comprising a combination of wo-
ven and lamellar bone within which vascular plexuses are
sandwiched. Secondary, Haversian (osteonal) remodelling in
sheep is more prevalent in old sheep. Aging results in sec-
ondary haversian remodeling that becomes more extensive
at specific locations, such as the posterior aspect of long
bones and in ribs.104 Haversian canal distribution has been
shown to be less dense in ovine bone than in human bone124
and has been described as not uniformly distributed.22 Dif-
ferences in bone density exist between the human and sheep,
whereby sheep bone shows a significantly higher density
and subsequently greater strength. Bone location must be
considered when contemplating differences between human
and sheep bones. In terms of mineral composition, humans
and animals do not show significant differences.22 Despite
the differences in bone structure being recognized, studies
show that sheep are a valuable model for human bone
turnover and remodeling activity.121 As found in other spe-
cies, it is likely that bone location may also alter bone com-
position and turnover in the sheep.22
Caprine models
As previously mentioned, goats are similar in size and
skeletal anatomy to sheep but have a thinner coat and less
muscular bulk, and are more tolerant to stress and isola-
tion.105 Goats are generally classified as gentle, inquisitive,
placid, and easy to handle, as well as clean and hardy in
nature,104 making them an increasingly viable alternative for
bone research.105 Like sheep, goats are considered food
producing animals and thus, also have the advantage of less
critical public perception when used for research, than
companion animals. When compared to other species, sheep
and goats are reported to be more tolerant to environmental
conditions.125 Histologically, the tibial cortical bone of goats
does not have homogeneously distributed Haversian sys-
tems (concentrically oriented lamellar bone containing a
centrally located blood vessel, also known as osteons). Si-
milar to the sheep, where the haversian systems are non-
uniformly distributed throughout individual bones, in the
goat, the Haversian systems are located primarily in the
cranial, cranio-lateral and medial sectors of the tibial diaph-
ysis, while the caudal sector is mainly comprised of lamellar
bone (where the collagen fibers are arranged in sheets and do
not contain a central blood vessel).126 Liebschner, in 200498
showed that, while there are small differences in the appar-
ent and ash density between the goat and humans, these
differences are probably not as significant as the differences
found between anatomic sites of the same species.98 The
mineral composition of bone does not vary significantly
across species and therefore, one could conclude that this
also holds true for the goat.22 Goat has a metabolic rate and
bone remodeling rate similar to that of human’s presenting a
suitable animal model for testing human implants and ma-
terials as they are considered.120,127 However, the rate at
which a bone graft is revascularised and converted into a
vital trabecular structure is found to be faster in the goat,
occurring at *3 months in comparison to 8 months in hu-
mans. There is little information comparing the utility of
goats versus sheep for implant-related studies. Therefore, the
choice of which small ruminant to use most likely depends
on availability and other factors.22
Cell culture approach
The possibility of isolating and expanding MSCs from a
small sample of bone marrow and directing them to the os-
teogenic phenotype has been demonstrated for both animals
(goats and sheep). Autologous approaches have also been
considered in previous studies demonstrating that both ovine
and caprine bone marrow MSCs have high viability and
proliferation rates when fresh or after being cryopre-
served,97,128–132 avoiding immune complex problems that in-
terfere with the regenerative process, as well as with the
patient follow-up. However, further studies should provide
better understanding of the importance of the differentiation
stage, as well as the time needed for osteogenic supplemen-
tation, to induce significant changes in bone formation
in vivo.133 Furthermore, future studies should also focus on
the standardization of animals used, considering different
races, different ages (young, adult, and old), because it is well
known that cells from different animals exhibit high vari-
ability in terms of proliferation and differentiation patterns.
Critical/Cylindrical Size Defects
Critical-sized defects are defined as ‘‘the smallest sized
intraosseous wound in a particular bone and animal species
that will not heal spontaneously during the ‘‘lifetime of the
animal’’103,134–136 or as a defect, which shows less than 10
percent bony regeneration during the lifetime of the ani-
mal.103,137 However, this has been redefined as segmental
bone deficiencies of a length exceeding 2–2.5 times the di-
ameter of the affected bone.103,138,139 Furthermore, critical
defect size should also be defined in relation to the evalua-
tion period of the study. For example, Pearce et al. 2007,22
refer that long term implantation periods for these species
are given as 12, 26, 52, and 78 weeks.22 Previous studies are
described in the literature using different implantation peri-
ods in large animal models. For example, Berner et al,140 re-
ported good results in terms of new bone formation upon
implantation of cell-scaffold constructs for 6 and 12 weeks,
while Rentsch et al.141 reported the same type of results upon
12 to 48 weeks of implantation, but the methodology used to
develop both studies was different.140,141
A critical defect in long bones, however, can hardly be
defined by size only. The phenomenon of regeneration is also
influenced by species, anatomic location, associated perios-
teum and soft tissue, and biomechanical conditions, as well
as age, metabolic and systemic influences, and related in-
juries affecting defect healing.103,134,138
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Congenital abnormalities, cancer resections, nonunions or
traumatic incidents are very common both in human and in
veterinary traumatology, and as suggested above, these
problems do not heal or regenerate spontaneously. In fact,
the currently available therapies that are usually used in such
clinical scenarios, mostly consisting on the use of auto or
allografts, present several disadvantages. Tissue engineering,
using scaffolds and stem cells offer the potential to overcome
such limitations. Therefore, it is important that studies on
scaffolds development for such applications envision the
need for obtaining constructs with a cylindrical shape, as
long bones show anatomically a cylindrical shape, and thus,
facilitating the translation to clinical settings. The composi-
tion of the defect generally includes periosteum, cortical
bone, and endosteum. After suture, the opening of the defect
is bounded by overlying muscle or fat. The base of the defect
may be cancellous bone and marrow, cortical bone, or
muscle/fat, depending on defect length and orientation
within the long bone. In general, defects in the metaphysis of
young large animals will be comprised of highly vascular
hematopoietic marrow. However, marrow in defects in the
diaphysis will generally be fatty or yellow marrow, which is
still vascular, but far less cellular. Advancing age in animals
will also increase the ratio of fatty to hematopoietic marrow,
changing the biological environment of the graft site. Soft
tissue encroachment does not compromise bone formation in
most cylindrical defects. Regardless, cylindrical critical de-
fects can be very sensitive to detecting differences in efficacy
between osteoconductive scaffold materials, as well as the
effects of bioactive factors and cell transplantation. The uni-
form radial geometry of cylindrical defects also provides the
potential for control and modeling of biological gradients
relevant to bone regeneration. Due to the pattern of diffusion
and vascular ingrowth that must be oriented from the pe-
riphery to the center of the defect, cylindrical defects are
particularly well suited for time-oriented studies of mass
transport (e.g., the influence of diffusion, cellular metabolic
demand, local oxygen delivery or generation, or gradients in
the delivery of bioactive factors), degradation rate of im-
plants, cell transplantation (survival and migration) and
variables modulating the rate of bone or tissue ingrowth or
vascular invasion into an implant.105
Creation of the Cylindrical Critical Size Defects
in Large Animals
Osteotomy approach techniques are used for the creation
of cylindrical critical size defects and can be performed by
using a CO2 Laser,
142,143 Oscillating saw,138,144–152 Gigli
saw,153,154 treaded saw155 and a chisel/osteotome.156–158 The
edges of the defect are usually cut straight with less trauma
but there are advantages and disadvantages in the choice of
each technique. The CO2 laser produces a cut with little
trauma, it’s the most accurate to perform the osteotomy but
quite expensive. Kuttenber et al.,143 demonstrated that bone
healing is similar and undelayed after both laser and oscil-
lating saw. For practical applications, precise control of the
depth of laser cutting and easier manipulation of the osteo-
tome are required.143 The oscillating saw makes a straight cut
without causing trauma to surrounding soft tissue and bone
thermal necrosis caused by cutting blade unit can be avoided
by a continuous irrigation of saline solution at the time of the
cut; the technique of holding the cutting is easy and fast and
cheaper when compared with the CO2, but more expensive
when compared with the manual saws. Manual saws are
much cheaper than all others, but require physical strength
to make the cut and the start of this may not be accurate due
to the difficulty of supporting the saw on the rounded and
smooth bone surface, and care must be taken not to cause
damage to surrounding soft tissues. The chisel (osteotomes)
techniques require a hammer to be performed, and is not the
best choice to perform an osteotomy in a long bone as it may
cause jagged cuts in the bone surface.
Fixation of the Cylindrical Critical Size Defects
in Large Animals
To simulate human in vivo conditions as closely as possi-
ble, a variety of large cylindrical critical size defect models,
mainly in sheep and goat, have been developed in the last
decade to investigate the influence of different types of bone
grafts on bone repair and regeneration. The method of fixa-
tion is an important variable to be studied in large cylindrical
critical size defect models. Fixation should not only reflect
what occurs in the clinic but also provide sufficient rigidity
to support bone healing.159 The method of fixation is more
important for defects within weight-bearing bones than the
nonweight-bearing bones.160 At present, most long bone
defect models use bone plates, interlocking intramedullary
nails, and external fixator to fix the defect; thus, reflecting the
situation within the clinic.159
Sufficient reduction and stability can be achieved by bone
plates even in complicated fractures.161 Bone plate osteo-
synthesis is performed using standard instrumentation, dif-
fering according to the size of the implant and the type of
plate fixation. Most studies on bone tissue engineering using
caprine and ovine models are performed in the diaphyseal
bone (tibia, femur) requiring the use of cortical screws that
are a very efficient devices for fixing a splinting device, such
as a plate. The goal is to achieve as much contact area as
possible in a sufficiently stable implant of minimal size; it is
recommended that the screw diameter should not exceed
40% of the diameter of the bone. There are a number of
different sizes of cortex screws available to enable fixation of
bones of different diameters. Newly developed screws for
use in humans, such as self-tapping screws, monocortical
screws and those used in locking systems, are likely to find
an increasing application in animal models. Various types of
bone plates are available in the market for use as bone fix-
ation methods, such as dynamic compression plates (DCP),
limited contact DCP (LC-DCP), locking compression plates
(LCP), non DCP and reconstruction plates. For sheep and
goat weighing between 15 and 45 kg, plates with screws of
3.5 and 4.5mm are used, but for weights superior of these
values the use of screws 5.5mm should be considered.
However, conventional bone plates can result in histologi-
cally and radiologically verifiable bone loss, which has been
attributed to stress protection (Wolff’s law). An increase in
cortical bone porosity proximate to the plate soon after bone
plate osteosynthesis has been observed. This porosity is ex-
plained by impaired vascular perfusion underneath the plate
due to high compression forces between plate, periosteum,
and bone.103,162 New plate systems were developed where
load and torque transmission act through the screws
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(interlocking screws), the stabilization system acts like an
external skeletal fixator (ESF) making a total plate–bone
contact unnecessary to achieve stable fixation.103 The plates
can be placed in three different functions: compression mode
(the plate creates an axial compression), neutralization mode
(the plate protects the interfragmentary compression), bio-
logical mode (the plate acts as a splint to maintain the correct
length of the bone and the normal spatial alignment of the
joints proximal and distal to the fracture).
For example, to study the effects of different bioceramics
during bone repair of a tibial defect model in sheep of 16mm
length, Gao et al.,163 implanted biocoral and TCP cylinders.
The defects were stabilized medially using two overlapping
contoured autocompression plates of 4mm thickness (eight
and six holes) and cortical screws.163 However, this method
of fixation is not commonly used in the clinical practice. A
DCP stainless steel plate was used by Kirker-Head et al.,164
for the stabilization of a 25mm long mid-diaphyseal critical
size defect in long bone of the sheep, to observe the use of
recombinant human BMP-2 and a poly [D, L-(lactide-co-
glycolide)] in 1 year of the long-term healing.164 Several
studies selected this as a method of fixation bone plate for
osteosynthesis. Wefer et al.,165 used as a method of fixing an
anterolateral plate to implant a porous hydroxyapatite scaf-
fold in a 20mm critical size defect in the sheep long bone, to
develop and test a scoring system based on real-time ultra-
sonography.165 Meinel et al.,148 performed a noncritical
10mm segmental tibia defect using for stabilization a 3.5mm
of 11 hole DCP plate, to study the treatment of bone defects
by releasing of the insulin-like growth factor(IGF-1) from
biodegradable poly(lactide-co-glycolide) microspheres.166 To
evaluate a synthetic calcium phosphate multiphase bioma-
terial, Mastrogiacomo et al.,167 created a 48mm tibial defect
model in sheep and stabilized with a 4.5mm neutralizing
plate.167 However, Reichert et al.,103 in their review article
reported that they observed bent plates and axial deviations
in presented X-ray and CT images, and concluded that the
chosen fixation, performed by Mastrogiacomo et al., seemed
insufficient in this study.103 Teixeira et al.,168 created a tibial
critical size defects of 35mm size, being the bone defects in
the diaphysis of the sheep stabilized with a titanium bone
plate (103mm in length, 2mm thickness, and 10mm width),
but as reported by the authors, plate bending occurred in
42% of the animals most likely caused by insufficient thick-
ness of the fixation device.168 To demonstrate that the com-
partmentalization of tissues may have an important role in
bone regeneration in long-bone defects, Klaue et al.,169 cre-
ated a foreign-body membrane with a temporary poly-
methylmethacrylate spacer with the same critical size of the
defect created (30mm) on mid-diaphyseal of the sheep fe-
murs and stabilized with an eight-hole, 4.5mm low covering
dynamic-compression plate (LC-DCP). The obtained results
suggested that regeneration of bone can be enhanced by
compartmentalisation of the bone defect.169 To study the
different immunological characteristics between Human and
ovine MSCs, Niemeyer et al.,150 applied a xenogenic trans-
plant (human MSCs) and an autologous transplant (ovine
MSCs) to a sheep animal model. For this purpose, they
performed a critical size defect of 30mm on the tibial di-
aphysis and stabilized it with a seven-hole LCP and self-
taping screw. The results demonstrated that the xenogenic
transplantation of human MSCs led to poorer bone regen-
eration than the autologous transplantation of ovine MSCs.
Nevertheless, no local or systemic rejection reactions could
be observed after xenogenic transplantation of human
MSCs.150 To investigate whether MSCs and osteogenic pro-
tein-1 (OP-1) can improve allograft integration, Bella et al.,170
performed a 30mm full-size bone defect in the mid-diaphysis
of the metatarsal bone of a sheep and stabilized with a seven-
hole titanium DCP (3.5mm wide, 10.5mm long). The results
demonstrated that the association of MSCs and OP-1 im-
prove bone allograft integration promoting an almost com-
plete bone restoring when compared to other groups:
allograft alone (control group), MSC group, OP-1 group.170
A locked intramedullary nail is a stainless steel nail in
which our titanium nail is placed within the medullary
cavity and is locked to the bone by screws or bolts crosses the
bone and passes through the holes in the nail. They are
available in several diameters and can be locked with screws
or bolts of 4.5 or 3.5mm diameter and are the most suitable
for use in ovine and caprine models. Locked intramedullary
nails resist bending, axial, and rotational forces because they
are locked with either bone screws or locking bolts. These are
most effectively used to stabilize mid-diaphyseal fractures of
the femur and tibia in animal models used in tissue engi-
neering approaches and in the last decade several researchers
have used this method for orthopedic fixation in their stud-
ies. To establish a new critical bone defect model of 30mm,
den Boer et al.,121 used an interlocking intramedullary nail
(AO unreamed humeral nail); the defect (30mm length)
was inflicted on sheep tibiae and bone healing was quanti-
fied through X-ray absorptiometry.121 A study conducted by
Bloemers et al.,171 indicated that new calcium phosphate
based materials might be a potential alternative for autolo-
gous bone grafts. To conduct this study, they used a seg-
mental tibial defect (30mm) in sheep fixed by an AO
unreamed interlocking titanium tibial nail.171 To see the ef-
fect of platelet rich plasma on new bone formation in a
25mm diaphyseal tibial defect in sheep, Sarkar et al.,172 sta-
bilized the defect with intramedullary nail with locking
screws on the proximal and distal surface and added stain-
less steel plate applied medially172 The effect of chondroitine
sulphate on bone remodeling and regeneration was investi-
gated by Schneiders et al.,173 for which they performed a
30mm tibial mid-diaphyseal defect site and reconstructed it
using hydroxyapatite/collagen cement cylinders. The stabi-
lization was achieved by insertion of a universal tibial nail
(UTN, Synthes; Bochum).173 To investigate the feasibility of
BMSCs on coral scaffold infected with adenoviral vector
containing the BMP-7 gene (AdBMP7), Zhu et al.,152 per-
formed a segmental bone defect of the 25mm in length at the
mid-portion of the femoral diaphysis of the goat, and stabi-
lized this defect with an internal fixation rod and interlock-
ing nails.152
The interlocking intramedullary nail can be applied in two
different ways, either static or dynamic compression. de-
pending on the number of screws to use and their position-
ing(distal or proximal), the outcome of animal experiments
and clinical retrievals strongly suggested that, particularly
the mechanical load, has a positive effect on bone graft in-
corporation.174–176 To prove this, Bullens et al.,151 studied if a
static or dynamic mode of nail fixation influenced the healing
of segmental defect reconstructions in long bones. In this
study, 35mm critical size defects in goat femurs were
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reconstructed using a cage filled with firmly impacted
morsellised allograft mixed with a hydroxyapatite paste
(Ostim). All reconstructions were stabilized with an inter-
locking intramedullary stainless steel unreamed femur nail
and AO locking screws. Authors found that healing of these
defects was not significantly influenced by the mode of fix-
ation of the nail in this animal model.151 To analyze the ef-
ficacy of allogeneic mesenchymal precursor cells in the repair
of sheep tibial segmental defects, Field et al.177 created 30mm
defects and stabilized them with a locking intramedullary
nail and allowed to heal over a 9-month-period. The group
treated with allogeneic cells and scaffolds displayed a sig-
nificantly greater level of callus formation and rate of
bone apposition in the defect, compared to the scaffolds
without cells.177
ESF and circular external fixation (Ilizarov model) are two
types of the bone fixation, which have been more widely
used in large animal studies, offering versatility and smooth
application. In fact, They offers major advantages over
‘‘conventional methods’’ in the management of fractures
caused by the creation of critical-size defects, as the fact that
they are relatively easy to apply, maintaining limb use and
joint mobility, are well tolerated by patients, have a low cost
when compared to plate systems, and involve a relatively
low risk procedure. In addition, external fixators are associ-
ated to minimal intra-operative trauma and the surrounding
soft tissues are only marginally affected. The linear external
fixators are composed of bars and clamps that can vary in
amount depending on the type to be applied (type I frame,
type II frame, and type III frame), being the type III frame the
most strong of all. The distal and proximal bone fragments
should be secured with at least two pins at each end, and the
conformation of these pins can be, smooth pin, negative and
positive threaded pins. One of the most common complica-
tions with linear external fixators is the pin loosening often
resulting in pin track infections, but this complication can be
eliminated with the use of positive threaded pins. The linear
external fixation has been selected by some research groups
as a method of bone fixation to be implemented. For exam-
ple, to study the effect of bioresorbable polylactide mem-
branes, applied alone and/or in combination with
autologous bone graft, in bone healing, Gugala et al.178 per-
formed a critical defect of 40mm in sheep tibia and stabilized
with an AO external fixator type II frame. Only in groups
where the defect was filled with autogenous cancellous bone
graft and covered with a membrane, defect healing was
observed.178 Maissen et al.179 studied the influence of
rhTGFbeta-3 loaded on a poly (L/DL-lactide) carrier, as
compared to the carrier only, autologous cancellous bone
graft, and to untreated defects, on mechanical and radio-
logical parameters of a healing bone defect in the sheep tibia.
An 18mm long defect was fixed with a unilateral (type I
frame) external fixator and the results showed significant
differences between the groups, indicating the autologous
cancellous bone graft bone graft treatment performed better
than the others group.179
Based on its design and configuration, circular fixators are
indicated for the treatment for lengthening or shortening
bone, limb deformities, arthrodesis, nonunion and fractures
by presenting greater rigidity and versatility, but few re-
searchers choose this method for bone fixation in their
studies in large animal models. Recently, Liu et al.,180 re-
ported on the use of highly porous b-TCP scaffolds to repair
26mm long goat tibial defects, stabilized using a circular
external fixator. Study groups included defects treated with
b-TCP ceramic cylinder loaded with osteogenically induced
autologous bone marrow stromal cells, beta-TCP ceramic
cylinder without cells and defects left untreated. X-ray, mCT
and histological analysis performed at 32 weeks post-
implantation showed that the porous beta-TCP ceramic cyl-
inder loaded with cells led to was significantly better results
than all the other groups.180
A 10 Year View from Now, on the Future of Bone
Tissue Engineering
Upon almost two decades of studies and developments in
the field of TERM, many aspects related to this area are yet to
be studied and/or developed. Drawbacks of of stem cell
based therapies that have already been identified, such as:
Heterogeneity of cell populations, genetic instability, high
mutation rate during in vitro manipulations, and immune
responses induced after stem cell transplantation, should be
deeply studied and understood to achieve efficient solutions.
Concerning the in vitro culture of scaffolds-cells constructs,
it is evident that bioreactors perfusion systems enable better
results regarding the induction of osteogenic differentiation
and de novo bone formation in vitro and in vivo, despite their
more complex designs, as compared to static culturing sys-
tems. Nevertheless, many progresses can be made to facili-
tate and overspread the utilization of these systems in future.
Studies should focus on determining optimal flow rates for
each bioreactor/scaffolds/cell type combination and de-
velop systems that can also be used for dynamic cell seeding,
without prejudice of initial cell adhesion and proliferation.
This could significantly reduce handling steps and enable
more efficient bioreactors.
Large animal models (often referred to as ‘‘nonrodent
species’’) provide important advantages for studies aimed at
assessing the in vivo functionality of TE constructs, including
the large size bones, similarity to human physiology, and
pathology and longer life, thereby facilitating the translation
of the studies outcomes for predicting the behavior in hu-
mans. However, animal model studies need to be improved
to better predict the effectiveness of the treatment strategies
in clinical trials. Several possible causes of the disparity be-
tween the results of animal studies and clinical trials have
been identified, including failure to acknowledge the limi-
tations of animal models, inadequate animal data and con-
clusions from them, less than optimal disease models and
overestimation of treatment efficacy. These problems should
be addressed in the design and execution of preclinical ani-
mal model studies involving bone stem-cell based therapies.
New horizons are opened in TERM, whether clinicians,
surgeons, scientists, and entrepreneurs begin to work in
multidisciplinary teams. These progresses will aid in ensur-
ing that TERM fulfills the expectations for revolutionizing
medical care.
Conclusions
Bone TERM has the potential to become a real alternative
to autologous bone grafts, but before this can happen it is
necessary to solve the problem of homogenously supplying
oxygen and nutrient to cells within a large scaffold. Several
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bioreactors have been developed that hold potential to im-
prove mass transfer in large cellular scaffold constructs and
to apply favorable mechanical stimuli; thus, facilitating the
cellular viability, proliferation and differentiation. One of the
major breakthroughs was the development of the perfusion
bioreactor system that increase the mass transfer of cellular
scaffolds not only at the periphery but also within the inte-
rior of scaffolds, increasing cellular proliferation, and osteo-
genic differentiation. A significant volume of work was
reported in this review, related to the use of perfusion bio-
reactor systems for bone tissue engineering. However, most
perfusion bioreactors described herein do not enable the
culture of large constructs. Thus, additional efforts are re-
quired to develop improved design for the successful culture
of large scaffolds to be used in clinical settings. Given the
amount of research conducted on many bioreactor systems,
the next obvious step should be the evaluation of constructs
developed in perfusion bioreactors, using large animal
models and critical size defects, to enable easier translation of
outcomes to the clinical scenario. However, little work has
been reported using perfusion bioreactor cultured bone tis-
sue engineering constructs implanted in critical size defects
animal models. Therefore, the selection of an experimental
model, to access the feasibility of a determined tissue engi-
neering concept, is critical to the success of the preclinical
studies and must be considered in the light of the proposed
ideas to be tested. The rapid progression of this research area
and the great number of novel developments must be sup-
ported by systematic assessment based on clinical practica-
bility and experience, the knowledge of basic biological
principles, medical needs and commercial practicality. Pre-
ferentially, an animal model should match the clinical setting
that it is to reflect, both in terms of creation of the defect and
the cells or scaffolds that will be used for repairing it. It is
clear that each of the species discussed here demonstrate
unique advantages and disadvantages in terms of their ap-
propriateness as a model for demonstrating the response of
bone tissue to an implant material. Considerations should
include the species and the type of defect (location, size,
method of creation and repair, and fixation), as well as the
post operation care and monitoring. Although there is no
ideal animal model, a deep understanding of the differences
of bone (macroscopic, microscopic and remodeling attri-
butes) are likely to improve the choice of model and inter-
pretation of these in vivo studies. Probably, a combination of
different animal models for different strategies may be more
realistic. However, to allow comparison between different
studies is fundamental that animal models, methods of or-
thopedic fixation, surgical procedures and devices for mea-
suring qualitatively, quantitatively and objectively the
samples are standardized to achieve a reliable data pool as a
base for future lines of research in TERM.
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